FIELD: medicine.
SUBSTANCE: invention concerns medicine, namely pulmonology, and can be used for treating community-acquired pneumonia in the patients with mid-severe and severe clinical course involving immunogram abnormalities. That is ensured by antibacterial therapy. In addition, for 3-4 day of treatment, the treatment regimen is supplemented with Polyoxidonium in a dose 6 mg daily intramuscularly within 5 days.
EFFECT: early positive dynamics of the main clinical symptoms of disease and normalisation of immunological indicators which allow reducing treatment time and preventing complications.
1 tbl, 1 ex, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN | 2012 |
|
RU2529782C2 |
METHOD OF TREATING CHRONIC TONSILLITIS | 2013 |
|
RU2530632C1 |
METHOD FOR IMMUNE CORRECTION IN PNEUMONIA | 2006 |
|
RU2305555C1 |
METHOD FOR TREATMENT OF ATOPIC DERMATITIS | 2004 |
|
RU2268737C2 |
METHOD OF SELECTING PREPARATION FOR IMMUNOTHERAPY OF SURGICAL PYOINFLAMMATORY DISEASES | 2008 |
|
RU2383892C1 |
METHOD FOR TREATING ACUTE CEREBRAL STROKE CASES | 2005 |
|
RU2268064C1 |
METHOD FOR CHOOSING PREPARATION FOR IMMUNOTHERAPY OF PURULENT-SEPTIC DISEASES | 2005 |
|
RU2288473C1 |
METHOD FOR PREVENTING LIVER INJURIES IN PERFORMING SHOCK-WAVE LITHOTRIPSY | 2006 |
|
RU2321413C1 |
METHOD OF YERSINIOSIS INFECTION TREATMENT FOR CHILDREN | 2007 |
|
RU2371174C2 |
METHOD FOR SECONDARY IMMUNODEFICIENCY DIAGNOSTICS | 2020 |
|
RU2749781C1 |
Authors
Dates
2009-12-10—Published
2008-06-23—Filed